CR Pharma

Harelbeke ·KBO/BCE: BE 0779.890.292

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	37.7%	40.0%	better than 48% of 140 sector peers
Net result	€190k	€54k	better than 80% of 140 sector peers
Equity	€813k	€155k	better than 79% of 140 sector peers
Gross operating margin	€287k	€110k	better than 75% of 138 sector peers
Employees (FTE)	0.0	0.4	better than 22% of 47 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€2.16M
Fixed assets	21/28	€1.92M
Tangible fixed assets	22/27	€1k
Financial fixed assets	28	€1.92M
Current assets	29/58	€241k
Amounts receivable within one year	40/41	€15k
Investments	50/53	€0
Cash & bank	54/58	€226k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€2.16M
Equity	10/15	€813k
Contributions / capital	10/11	€604k
Reserves	13	€209k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€1.34M
Amounts payable after one year	17	€1.04M
Amounts payable within one year	42/48	€306k
Trade debts payable within one year	44	€966
Income statement
Gross operating margin	9900	€287k
Operating result	9901	€285k
Financial income	75	€3k
Financial charges	65	€40k
Result before taxes	9903	€248k
Income taxes	67/77	€58k
Net result for the period	9904	€190k
Result to be appropriated	9905	€190k

Parcel (capakey)	Region	Area	Buildings	Height / fl.
34023B0694/00W007	Flanders	726 m²	1 · 125 m²	11.8 m · 3 fl.
34323D0072/00R005	Flanders	376 m²	1 · 351 m²	11.9 m · 1 fl.

Summary